title: PKCθ: a new target for selective immunosuppression.
authors.forename: Amnon
authors.initials: A
authors.lastname: Altman
authors.forename: Kok-Fai
authors.initials: KF
authors.lastname: Kong
mesh_terms: D000818:Animals; D006084:Graft Rejection / Q000188:drug therapy* / Q000276:immunology; D006086:Graft vs Host Disease / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007165:Immunosuppression Therapy; D007527:Isoenzymes / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D051379:Mice; D018345:Mice, Knockout; D058990:Molecular Targeted Therapy; D016328:NF-kappa B / Q000378:metabolism; D011493:Protein Kinase C / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D000074121:Protein Kinase C-theta; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D011565:Psoriasis / Q000188:drug therapy* / Q000276:immunology; D011758:Pyrroles / Q000627:therapeutic use; D011799:Quinazolines / Q000627:therapeutic use; D015398:Signal Transduction; D013601:T-Lymphocytes / Q000276:immunology / Q000378:metabolism* / Q000473:pathology
chemical_list: D007527:Isoenzymes; D016328:NF-kappa B; D047428:Protein Kinase Inhibitors; D011758:Pyrroles; D011799:Quinazolines; C543528:sotrastaurin; C076233:PRKCQ protein, human; C489593:Prkcq protein, mouse; D011493:Protein Kinase C; D000074121:Protein Kinase C-theta